Immune Characteristics in Alzheimer's Disease and Dementia With Lewy Bodies
Author Information
Author(s): Qiu Conglong, Zhang Danhua, Wang Majie, Mei Xi, Chen Wei, Yu Haihang, Yin Weiwei, Peng Guoping, Hu Shaohua
Primary Institution: Zhejiang University School of Medicine
Hypothesis
Peripheral blood mononuclear cells (PBMCs) can accurately reflect the immune characteristics of Alzheimer's disease (AD) and dementia with Lewy bodies (DLB).
Conclusion
Peripheral immune characteristics could serve as potential biomarkers for diagnosing neurodegenerative diseases.
Supporting Evidence
- AD patients showed lower levels of T cells compared to healthy controls.
- DLB patients exhibited lower levels of T cells compared to healthy controls.
- The diagnostic efficacy of the immune model surpassed that of plasma p-Tau181 and NFL.
Takeaway
Scientists studied blood cells to find differences between Alzheimer's and Lewy body dementia, helping doctors diagnose these diseases better.
Methodology
Time-of-flight mass cytometry (CyTOF) was used to analyze PBMCs from participants with AD, DLB, and healthy controls.
Potential Biases
The study's findings may be influenced by the gender imbalance in the sample population.
Limitations
The study had a small sample size and was cross-sectional, lacking longitudinal data.
Participant Demographics
The study included 14 AD patients, 25 DLB patients, and 18 healthy controls, with a mean age of 76.79 years for AD, 72.12 years for DLB, and 73.72 years for healthy controls.
Statistical Information
P-Value
p<0.001 for T cell levels in AD compared to healthy controls.
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website